Friday, July 28, 2023 5:00:23 PM
1) It was for tax obligations like an other stock RSU's
2) NASDAQ compliant today (10 days over $1)
3) there is no R/S, but there is a vote for one (NASDAQ compliant might make that useless now)
4) settled lawsuit = great
5) share dilution at $5.75 was the right call considering this dropped below a $1 and would have had to dilute more if they waited
1. Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 25, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 25, 2022, and timely reported on a Form 4 filed on July 25, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after July 25, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.
https://www.sec.gov/Archives/edgar/data/1801170/000089534523000420/xslF345X05/form4.xml
Recent CLOV News
- Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/23/2024 08:05:00 PM
- Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer • GlobeNewswire Inc. • 04/22/2024 08:05:00 PM
- Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions • GlobeNewswire Inc. • 04/04/2024 08:30:00 PM
- Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness • GlobeNewswire Inc. • 03/19/2024 01:00:00 PM
- Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading • IH Market News • 03/12/2024 11:22:57 AM
- Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/16/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:41:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:25:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 08:51:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:10:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:21:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:31:57 PM
- Clover Health Provides Business Update and Full-Year 2024 Objectives • GlobeNewswire Inc. • 01/10/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:03:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:02:24 PM
- PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent • GlobeNewswire Inc. • 01/08/2024 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:30:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:26:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:16:30 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM